Result Summary for 112076
| Protocol ID: | 112076 |
| Clinical Study ID: | 112076 |
| Official Title: | A study to evaluate GlaxoSmithKline (GSK) Biologicals’ investigational vaccination regimen in healthy young adults |
| Phase: | phase 1 |
| Study Indications or Diseases: |
|
| Generic Name: | Hepatitis B Vaccine, Recombinant |
| Trade/Product Name: | Engerix-B |
| Approved Drug Label: | http://www.gsk.com/products.html |
| Results Summary: |  Click
here to download result summary. |
| Citations: |
|
The summaries are in PDF format. If you do not have Adobe® Acrobat® Reader™ installed, you can download it for free.
